IN THE NEWS

Updates that matter. News to know.

 

 

Stay informed with the latest company news, product updates, and media coverage from Dexcel Pharma USA. From scientific advancements to industry insights, this is where we share the moments that shape our mission and move healthcare forward.

In The News

Yargesa (miglustat) Capsules Receives CHMP Positive Opinion

Parsippany, New Jersey. Edenbridge Pharmaceuticals announces Yargesa (100mg miglustat capsules) receives CHMP Positive Opinion. Final approval will be first European Union-wide generic of Actelion's Zavesca®* through the centralized procedure. Edenbridge...

read more

Ethacrynic Acid Tablets, USP Approval

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Valeant Pharmaceuticals' Edecrin®* tablets...

read more

Carbidopa Tablets Launch

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Lodosyn®* (Carbidopa Tablets 25mg). Edenbridge will...

read more

Bumetanide Tablets, USP Launch

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that it has partnered with Validus Pharmaceuticals LLC to launch an exclusive authorized generic version of Bumex®* (bumetanide tablets). Edenbridge's Bumetanide Tablets in 0.5mg, 1mg and 2mg...

read more

Tinidazole Tablets Approval

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Tindamax®* (Tinidazole Tablets 250mg & 500mg)....

read more

Ivermectin Tablets, USP Approval

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Merck & Co., Inc.'s Stromectol®* (Ivermectin...

read more

Stavudine for Oral Solution, USP Launch

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC, is pleased to announce the launch of Stavudine for Oral Solution, USP. Edenbridge's Stavudine is the only FDA approved generic version of Zerit®* for Oral Solution currently available on the market. For more...

read more

Opium Tincture, USP (Deodorized) Launch

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC, is pleased to announce the launch of its newest product Opium Tincture, USP (Deodorized). For more information, please visit our updated Products page or contact us directly at info@dexcelpharmausa.com.

read more

Explore Dexcel Pharma USA

Meet Our Leadership

Our leadership team brings together deep industry expertise, strategic vision, and a shared passion for improving patient lives.

Explore Our Resources

Explore the latest developments at Dexcel Pharma USA, detailed product information, and opportunities for business development partnerships.

Partner With Us

We are committed to building long-term partnerships in every aspect of our business.